NasdaqGS - Nasdaq Real Time Price USD
Rigel Pharmaceuticals, Inc. (RIGL)
20.15
+0.95
+(4.95%)
At close: June 2 at 4:00:00 PM EDT
19.80
-0.35
(-1.74%)
After hours: June 2 at 7:30:16 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 5 |
| Avg. Estimate | 1.4 | 0.24 | 2.26 | 1.98 |
| Low Estimate | 0.14 | 0.08 | 0.93 | 1.05 |
| High Estimate | 2.78 | 0.38 | 3.98 | 3.29 |
| Year Ago EPS | -0.06 | 0.7 | 0.99 | 2.26 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 6 |
| Avg. Estimate | 64.58M | 50.55M | 216.75M | 233.22M |
| Low Estimate | 47.5M | 49.17M | 188.76M | 221.6M |
| High Estimate | 89.8M | 51.33M | 249.03M | 260.5M |
| Year Ago Sales | 36.84M | 55.31M | 179.28M | 216.75M |
| Sales Growth (year/est) | 75.29% | -8.60% | 20.90% | 7.60% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.18 | 0.06 | 0.58 | 0.09 |
| EPS Actual | -0.06 | 0.7 | 0.8 | 0.63 |
| Difference | 0.12 | 0.64 | 0.22 | 0.54 |
| Surprise % | 66.22% | 990.85% | 38.19% | 605.80% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.4 | 0.24 | 2.26 | 1.98 |
| 7 Days Ago | 1.4 | 0.24 | 2.26 | 1.98 |
| 30 Days Ago | 0.31 | 0.31 | 1.24 | 1.79 |
| 60 Days Ago | 0.31 | 0.31 | 1.24 | 1.79 |
| 90 Days Ago | 0.27 | 0.16 | 1.18 | 1.96 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | -- |
| Up Last 30 Days | 1 | 1 | 3 | 1 |
| Down Last 7 Days | 1 | 1 | 3 | 5 |
| Down Last 30 Days | -- | -- | 2 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RIGL | 2,441.67% | -65.36% | 127.81% | -12.04% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Maintains | Cantor Fitzgerald: Neutral to Neutral | 5/7/2025 |
| Maintains | Citigroup: Buy to Buy | 3/6/2025 |
| Maintains | B. Riley Securities: Neutral to Neutral | 3/5/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/5/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/23/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/22/2025 |
Related Tickers
ATYR aTyr Pharma, Inc.
4.7500
+6.26%
PYPD PolyPid Ltd.
2.9500
+5.36%
PLRZ Polyrizon Ltd.
0.7690
-15.78%
VSTM Verastem, Inc.
6.02
-19.95%
CRIS Curis, Inc.
2.4400
-0.41%
CTMX CytomX Therapeutics, Inc.
2.5100
-5.28%
ORIC ORIC Pharmaceuticals, Inc.
8.47
+3.67%
FOLD Amicus Therapeutics, Inc.
6.16
+1.48%
CRMD CorMedix Inc.
12.70
+4.61%
DAWN Day One Biopharmaceuticals, Inc.
7.01
+9.87%